SE8505112D0 - Novel pharmacological compounds - Google Patents

Novel pharmacological compounds

Info

Publication number
SE8505112D0
SE8505112D0 SE8505112A SE8505112A SE8505112D0 SE 8505112 D0 SE8505112 D0 SE 8505112D0 SE 8505112 A SE8505112 A SE 8505112A SE 8505112 A SE8505112 A SE 8505112A SE 8505112 D0 SE8505112 D0 SE 8505112D0
Authority
SE
Sweden
Prior art keywords
pharmacological compounds
novel pharmacological
compounds
novel
chem
Prior art date
Application number
SE8505112A
Other languages
English (en)
Swedish (sv)
Inventor
T B Alminger
H S Larsson
P L Lindberg
G E Sunden
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Priority to SE8505112A priority Critical patent/SE8505112D0/xx
Publication of SE8505112D0 publication Critical patent/SE8505112D0/xx
Priority to ZA867716A priority patent/ZA867716B/xx
Priority to EG661/86A priority patent/EG17753A/xx
Priority to NZ218028A priority patent/NZ218028A/xx
Priority to IE280586A priority patent/IE59167B1/en
Priority to PH34408A priority patent/PH25319A/en
Priority to DD86295633A priority patent/DD252375A5/de
Priority to MYPI86000038A priority patent/MY101791A/en
Priority to JO19861502A priority patent/JO1502B1/en
Priority to AT86906498T priority patent/ATE79619T1/de
Priority to JP61505700A priority patent/JPH0780874B2/ja
Priority to AU65429/86A priority patent/AU598491B2/en
Priority to EP86850378A priority patent/EP0221041A3/en
Priority to EP86906498A priority patent/EP0233284B1/en
Priority to HU865443A priority patent/HU198474B/hu
Priority to ES86906498T priority patent/ES2051696T3/es
Priority to IL80437A priority patent/IL80437A0/xx
Priority to KR1019870700555A priority patent/KR950009858B1/ko
Priority to PCT/SE1986/000493 priority patent/WO1987002668A1/en
Priority to DE8686906498T priority patent/DE3686483T2/de
Priority to IS3156A priority patent/IS1564B/is
Priority to PT83647A priority patent/PT83647B/pt
Priority to CN86107595A priority patent/CN1022487C/zh
Priority to CS782686A priority patent/CS272767B2/cs
Priority to PL1986262105A priority patent/PL150240B1/pl
Priority to DK320587A priority patent/DK320587A/da
Priority to NO872686A priority patent/NO171365C/no
Priority to FI872864A priority patent/FI91151C/fi
Priority to PH36882A priority patent/PH27126A/en
Priority to US07/195,343 priority patent/US5021433A/en
Priority to GR920402498T priority patent/GR3006177T3/el
Priority to LVP-93-856A priority patent/LV10270B/xx
Priority to LTIP1681A priority patent/LTIP1681A/xx
Priority to JP6318132A priority patent/JPH0826014B2/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
SE8505112A 1985-10-29 1985-10-29 Novel pharmacological compounds SE8505112D0 (sv)

Priority Applications (34)

Application Number Priority Date Filing Date Title
SE8505112A SE8505112D0 (sv) 1985-10-29 1985-10-29 Novel pharmacological compounds
ZA867716A ZA867716B (en) 1985-10-29 1986-10-09 Novel pharmacological compounds
EG661/86A EG17753A (en) 1985-10-29 1986-10-22 Novel pharmacological compounds
NZ218028A NZ218028A (en) 1985-10-29 1986-10-22 Benzimidazole derivatives and pharmaceutical compositions
IE280586A IE59167B1 (en) 1985-10-29 1986-10-23 Novel pharmacological compounds
PH34408A PH25319A (fi) 1985-10-29 1986-10-24
DD86295633A DD252375A5 (de) 1985-10-29 1986-10-27 Verfahren zur herstellung von benzimidazolderivaten
MYPI86000038A MY101791A (en) 1985-10-29 1986-10-27 New benzimidazole derivatives
JO19861502A JO1502B1 (en) 1985-10-29 1986-10-27 New pharmacy vehicles
IS3156A IS1564B (is) 1985-10-29 1986-10-28 Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
IL80437A IL80437A0 (en) 1985-10-29 1986-10-28 Benzimidazole derivatives and pharmaceutical compositions containing them
JP61505700A JPH0780874B2 (ja) 1985-10-29 1986-10-28 新規な薬理活性化合物
AU65429/86A AU598491B2 (en) 1985-10-29 1986-10-28 Pyridyl-methylthio substituted benzimidazoles
EP86850378A EP0221041A3 (en) 1985-10-29 1986-10-28 Benzimidazole derivatives, process for their preparation and their pharmaceutical use
EP86906498A EP0233284B1 (en) 1985-10-29 1986-10-28 Pharmacological compounds
HU865443A HU198474B (en) 1985-10-29 1986-10-28 Process for producing benzimidazole derivatives and pharmaceutical compositions comprising same
ES86906498T ES2051696T3 (es) 1985-10-29 1986-10-28 Un procedimiento para la preparacion de compuestos farmacologicos.
AT86906498T ATE79619T1 (de) 1985-10-29 1986-10-28 Arzneimittel.
KR1019870700555A KR950009858B1 (ko) 1985-10-29 1986-10-28 신규의 벤즈이미다졸 유도체의 제조 방법
PCT/SE1986/000493 WO1987002668A1 (en) 1985-10-29 1986-10-28 Novel pharmacological compounds
DE8686906498T DE3686483T2 (de) 1985-10-29 1986-10-28 Arzneimittel.
PL1986262105A PL150240B1 (en) 1985-10-29 1986-10-29 The method of manufacture of new derivatives of benzimidazole
CN86107595A CN1022487C (zh) 1985-10-29 1986-10-29 制备新的药物化合物
PT83647A PT83647B (pt) 1985-10-29 1986-10-29 Processo para a preparacao de novos derivados de benzimidazole com actividade farmacologica e de composicoes farmaceuticas que os contem
CS782686A CS272767B2 (en) 1985-10-29 1986-10-29 Method of benzimidazole derivatives production
DK320587A DK320587A (da) 1985-10-29 1987-06-24 Nye farmakologiske forbindelser
NO872686A NO171365C (no) 1985-10-29 1987-06-26 Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
FI872864A FI91151C (fi) 1985-10-29 1987-06-29 Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
PH36882A PH27126A (en) 1985-10-29 1988-05-04 Novel benzimidazole derivatives
US07/195,343 US5021433A (en) 1985-10-29 1988-05-12 Novel pharmacological compounds
GR920402498T GR3006177T3 (fi) 1985-10-29 1992-11-05
LVP-93-856A LV10270B (en) 1985-10-29 1993-06-30 Novel pharmacological compounds
LTIP1681A LTIP1681A (en) 1985-10-29 1993-12-28 Novel pharmacological compounds
JP6318132A JPH0826014B2 (ja) 1985-10-29 1994-12-21 新規中間体

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8505112A SE8505112D0 (sv) 1985-10-29 1985-10-29 Novel pharmacological compounds

Publications (1)

Publication Number Publication Date
SE8505112D0 true SE8505112D0 (sv) 1985-10-29

Family

ID=20361960

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8505112A SE8505112D0 (sv) 1985-10-29 1985-10-29 Novel pharmacological compounds

Country Status (31)

Country Link
US (1) US5021433A (fi)
EP (2) EP0233284B1 (fi)
JP (2) JPH0780874B2 (fi)
KR (1) KR950009858B1 (fi)
CN (1) CN1022487C (fi)
AT (1) ATE79619T1 (fi)
AU (1) AU598491B2 (fi)
CS (1) CS272767B2 (fi)
DD (1) DD252375A5 (fi)
DE (1) DE3686483T2 (fi)
DK (1) DK320587A (fi)
EG (1) EG17753A (fi)
ES (1) ES2051696T3 (fi)
FI (1) FI91151C (fi)
GR (1) GR3006177T3 (fi)
HU (1) HU198474B (fi)
IE (1) IE59167B1 (fi)
IL (1) IL80437A0 (fi)
IS (1) IS1564B (fi)
JO (1) JO1502B1 (fi)
LT (1) LTIP1681A (fi)
LV (1) LV10270B (fi)
MY (1) MY101791A (fi)
NO (1) NO171365C (fi)
NZ (1) NZ218028A (fi)
PH (1) PH25319A (fi)
PL (1) PL150240B1 (fi)
PT (1) PT83647B (fi)
SE (1) SE8505112D0 (fi)
WO (1) WO1987002668A1 (fi)
ZA (1) ZA867716B (fi)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ234564A (en) * 1986-11-21 1991-04-26 Haessle Ab 1-substituted benzimidazoles and pharmaceutical compositions
KR920003928B1 (ko) * 1988-09-20 1992-05-18 히사미쯔세이야꾸 가부시기가이샤 신규의 디벤즈[b,e]옥세핀유도체
SE8804629D0 (sv) * 1988-12-22 1988-12-22 Ab Haessle New therapeutically active compounds
IE64199B1 (en) * 1988-12-22 1995-07-12 Haessle Ab Compound with gastric acid inhibitory effect and process for its preparation
US4965269A (en) * 1989-12-20 1990-10-23 Ab Hassle Therapeutically active chloro substituted benzimidazoles
US5274099A (en) * 1989-12-20 1993-12-28 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
US5049674A (en) * 1989-12-20 1991-09-17 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
SE9002206D0 (sv) * 1990-06-20 1990-06-20 Haessle Ab New compounds
PL166209B1 (pl) * 1990-06-20 1995-04-28 Astra Ab Sposób wytwarzania nowych pochodnych benzimidazolu PL
ES2048109B1 (es) * 1992-07-20 1994-12-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados piperidicos del bencimidazol.
WO1995032957A1 (en) * 1994-05-27 1995-12-07 Astra Aktiebolag Novel ethoxycarbonyloxymethyl derivatives of substituted benzimidazoles
US6093734A (en) * 1998-08-10 2000-07-25 Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin Prodrugs of proton pump inhibitors
CN100396675C (zh) 1998-08-10 2008-06-25 加利福尼亚州大学董事会 质子泵抑制剂的前药
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
US6369087B1 (en) * 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
WO2002030920A1 (fr) * 2000-10-12 2002-04-18 Takeda Chemical Industries, Ltd. Composes derives de benzimidazole, leur procede de production et leur utilisation
WO2003027098A1 (fr) * 2001-09-25 2003-04-03 Takeda Chemical Industries, Ltd. Compose de benzymidazole, procede de production et d'utilisation de celui-ci
WO2003105845A1 (en) * 2002-06-14 2003-12-24 Takeda Chemical Industries, Ltd. Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers
US6897227B2 (en) * 2002-07-19 2005-05-24 Winston Pharmaceuticals, Inc. Prodrugs of proton pump inhibitors
US7211590B2 (en) 2002-08-01 2007-05-01 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
WO2004112756A1 (en) * 2003-06-26 2004-12-29 Isa Odidi Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US20050075371A1 (en) * 2003-10-03 2005-04-07 Allergan, Inc. Methods and compositions for the oral administration of prodrugs of proton pump inhibitors
WO2005039640A1 (en) * 2003-10-03 2005-05-06 Allergan Inc. Compositions comprising trefoil factor family peptides and/or mucoadhesives and proton pump inhibitor prodrugs
US20070161679A1 (en) * 2004-02-18 2007-07-12 Allergan, Inc. Method and compositions for the intravenous administration of compounds related to proton pump inhibitors
JP2007523163A (ja) * 2004-02-18 2007-08-16 アラーガン、インコーポレイテッド プロトンポンプインヒビターのプロドラッグの投与のための方法および組成物
CA2561700A1 (en) * 2004-04-16 2005-12-15 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and prokinetic agent
WO2005105786A1 (en) * 2004-04-28 2005-11-10 Hetero Drugs Limited A process for preparing pyridinylmethyl-1h- benzimidazole compounds in enantiomerically enriched form or as single enantiomers
DE602004025386D1 (de) 2004-05-28 2010-03-18 Hetero Drugs Ltd Neue stereoselektive synthese von benzimidazolsulfoxiden
US8394409B2 (en) * 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US9561188B2 (en) * 2006-04-03 2017-02-07 Intellipharmaceutics Corporation Controlled release delivery device comprising an organosol coat
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
US20100317689A1 (en) * 2006-09-19 2010-12-16 Garst Michael E Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety
EP2486910A3 (en) 2006-10-27 2012-08-22 The Curators Of The University Of Missouri Multi-chambered apparatus comprising a dispenser head
US20080194307A1 (en) * 2007-02-13 2008-08-14 Jeff Sanger Sports-based game of chance
EP2252274A4 (en) 2008-02-20 2011-05-11 Univ Missouri COMPOSITION COMPRISING A COMBINATION OF OMEPRAZOLE AND LANSOPRAZOLE, AND A BUFFER AGENT, AND METHODS OF USING THE SAME
AU2010339691B2 (en) * 2010-01-07 2015-04-02 Alkermes Pharma Ireland Limited Prodrugs of heteraromatic compounds

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR320097A (fr) * 1902-04-01 1902-12-01 Betts Perfectionnements dans et relatifs au raffinage électrolytique du plomb et des alliages de plomb
FR1474663A (fr) * 1966-04-06 1967-03-24 Electrolyt Zinc Australasia Procédé d'extraction de métaux
US4026776A (en) * 1970-12-02 1977-05-31 Mitsui Mining & Smelting Co., Ltd. Method for producing high purity lead
US4045564A (en) * 1974-02-18 1977-08-30 Ab Hassle Benzimidazole derivatives useful as gastric acid secretion inhibitors
SE418966B (sv) * 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
US3960681A (en) * 1974-02-21 1976-06-01 Mitsui Mining & Smelting Co., Ltd. Method for producing electrolytic high purity lead using large-sized electrodes
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
NZ181123A (en) * 1975-06-30 1979-12-11 Univ Melbourne Treatment of mineralcontaining materials with an acid in the presence of fluoride ion
US3972790A (en) * 1975-09-26 1976-08-03 Uop Inc. Production of metallic lead
IN148930B (fi) * 1977-09-19 1981-07-25 Hoffmann La Roche
US4189461A (en) * 1977-11-30 1980-02-19 Kennecott Copper Corporation Metal leaching from concentrates using nitrogen dioxide in acids
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
FR2446863A1 (fr) * 1979-01-22 1980-08-14 Uop Inc Procede perfectionne de recuperation de plomb
FR2453906A1 (fr) * 1979-04-12 1980-11-07 Uop Inc Procede de preparation hydrometallurgique de plomb a l'aide d'une extraction par voie electrochimique
US4229271A (en) * 1979-05-24 1980-10-21 Rsr Corporation Method of recovering lead values from battery sludge
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
CH644116A5 (de) * 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
FR2505876A1 (en) * 1981-05-12 1982-11-19 Noual Patrick Selective winning of lead from sulphide ores - by leaching with hot aq. hydro:fluorosilicic acid soln. contg. hydrogen peroxide and air so only lead is dissolved
SE8300736D0 (sv) * 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
US4500398A (en) * 1984-06-20 1985-02-19 The United States Of America As Represented By The Secretary Of The Interior Production of lead from sulfides
ZA856671B (en) * 1984-09-24 1986-04-30 Upjohn Co N-substituted derivatives of 2-(pyridylaklenesulfinyl)benzimidazoles as gastric antisecretory agents
AU568441B2 (en) * 1984-09-24 1987-12-24 Upjohn Company, The 2-(pyridylalkenesulfinyl) benzimidazole derivatives

Also Published As

Publication number Publication date
HU198474B (en) 1989-10-30
NO872686L (no) 1987-06-26
EP0233284B1 (en) 1992-08-19
EP0233284A1 (en) 1987-08-26
PL262105A1 (en) 1988-08-18
EP0221041A3 (en) 1987-10-28
DE3686483T2 (de) 1993-02-04
DD252375A5 (de) 1987-12-16
HUT43843A (en) 1987-12-28
KR870700620A (ko) 1987-12-30
IS3156A7 (is) 1987-04-30
CS782686A2 (en) 1990-05-14
FI91151B (fi) 1994-02-15
FI91151C (fi) 1994-05-25
DK320587D0 (da) 1987-06-24
MY101791A (en) 1992-01-31
LTIP1681A (en) 1995-09-25
KR950009858B1 (ko) 1995-08-29
NO171365B (no) 1992-11-23
US5021433A (en) 1991-06-04
WO1987002668A1 (en) 1987-05-07
NZ218028A (en) 1990-02-26
LV10270A (lv) 1994-10-20
JPH07188216A (ja) 1995-07-25
AU6542986A (en) 1987-05-19
PH25319A (fi) 1991-04-30
CN1022487C (zh) 1993-10-20
DE3686483D1 (de) 1992-09-24
JPH0780874B2 (ja) 1995-08-30
IE59167B1 (en) 1994-01-12
CS272767B2 (en) 1991-02-12
ES2051696T3 (es) 1994-07-01
DK320587A (da) 1987-06-24
JPH0826014B2 (ja) 1996-03-13
NO171365C (no) 1993-03-03
CN86107595A (zh) 1987-07-08
IS1564B (is) 1994-12-13
FI872864A (fi) 1987-06-29
NO872686D0 (no) 1987-06-26
EG17753A (en) 1991-12-30
FI872864A0 (fi) 1987-06-29
EP0221041A2 (en) 1987-05-06
AU598491B2 (en) 1990-06-28
IL80437A0 (en) 1987-01-30
IE862805L (en) 1987-04-29
PT83647B (pt) 1989-05-31
JPS63501151A (ja) 1988-04-28
PT83647A (en) 1986-11-01
ZA867716B (en) 1987-05-27
JO1502B1 (en) 1989-01-25
LV10270B (en) 1995-04-20
PL150240B1 (en) 1990-05-31
ATE79619T1 (de) 1992-09-15
GR3006177T3 (fi) 1993-06-21

Similar Documents

Publication Publication Date Title
SE8505112D0 (sv) Novel pharmacological compounds
SE8300736D0 (sv) Novel pharmacologically active compounds
MY101784A (en) Novel pharmacological compounds
SE8404065D0 (sv) Novel biologically active compounds
IT1224405B (it) Composti attivi sul sistema cardiovascolare
SE8600658D0 (sv) Novel composition of matter
SE8405588D0 (sv) New compounds
DE3853958D1 (de) Substituierte Pyridin-Verbindungen, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.
SE8704049D0 (sv) Novel pharmacological compounds
IT1224404B (it) Composti attivi sul sistema cardiovascolare